Report an error

Spotted something inaccurate in “SGLT2 Inhibitor Dapagliflozin Fails to Cut Post-Cardiac Surgery Kidney Injury Risk”? Tell us what’s wrong and we’ll check it against the original source.

Website

Send report Cancel

This form is for factual corrections. We read every report but cannot reply individually.